Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Aguilera-Alonso, David
  • Solis-Garcia, Gonzalo
  • Noguera-Julian, Antoni
  • Gonzalez-Martin, Julian
  • Roman Cobena, Angely
  • Baquero-Artigao, Fernando
  • Toro Rueda, Carlos
  • Rodriguez-Molino, Paula
  • Bloise Sanchez, Ivan
  • Vallmanya, Teresa
  • Bernet-Sanchez, Albert
  • Minguell Domingo, Laura
  • Rubio, Adriana
  • Saavedra-Lozano, Jesus
  • Jesus Ruiz-Serrano, Maria
  • Blazquez-Gamero, Daniel
  • Lopez-Roa, Paula
  • Gomez-Pastrana, David
  • Lopez Prieto, Maria Dolores
  • Lopez Medina, Eva Maria
  • Martin Nalda, Andrea
  • Soriano-Arandes, Antonio
  • Tortola, Teresa
  • Falcon-Neyra, Lola
  • Gonzalez Galan, Veronica
  • Tebruegge, Marc
  • Santiago-Garcia, Begona

Grupos

Abstract

Introduction Childhood pulmonary tuberculosis (TB) remains a diagnostic challenge. This study aimed to evaluate the performance of Xpert Ultra for the diagnosis of pulmonary TB in children in a low TB prevalence setting. Methods Prospective, multicentre, diagnostic accuracy study. Children with clinical or radiological suspicion of pulmonary TB were recruited at 11 paediatric units in Spain. Up to three gastric or sputum specimens were taken on 3 consecutive days, and analysed by Xpert MTB/RIF, Xpert Ultra and culture in parallel. Results 86 children were included (median age 4.9 years, IQR 2.0-10.0; 51.2% male). The final diagnosis was pulmonary TB in 75 patients (87.2%); 33 (44.0%) were microbiologically confirmed. A total of 219 specimens, comprising gastric aspirates (n=194; 88.6%) and sputum specimens (n=25; 11.4%), were analysed. Using culture as reference standard and comparing individual specimens, the sensitivity was 37.8% (14/37) for Xpert MTB/RIF and 81.1% (30/37) for Xpert Ultra (p<0.001); specificity was 98.4% (179/182) and 93.4% (170/182), respectively (p=0.02). In the per-patient analysis, considering positive results on any specimen, the sensitivity was 42.9% (9/21) for Xpert MTB/RIF and 81.0% for Xpert Ultra (17/21, p=0.01); specificity was 96.9% (63/65) and 87.7% (57/65, p=0.07), respectively. Conclusions In children with pulmonary TB in a low burden setting, Xpert Ultra has significantly higher sensitivity than the previous generation of Xpert assay and only marginally lower specificity. Therefore, in children undergoing evaluation for suspected pulmonary TB, Xpert Ultra should be used in preference to Xpert MTB/RIF whenever possible.

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Datos de la publicación

ISSN/ISSNe:
0040-6376, 1468-3296

Thorax  BMJ PUBLISHING GROUP

Tipo:
Article
Páginas:
1023-1029
Factor de Impacto:
2,309 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 5

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Tuberculosis; Paediatric Lung Disaese; Respiratory Infection

Campos de estudio

Cita

Compartir